Search Results - "Yip, Peter CW"

Grave impact of undetected rpoB I572F mutation on clinical course of multidrug-resistant tuberculosis: a case report by Chan, A C K, Chan, M C H, Yip, P C W, Yam, W C, Chau, C H, Lam, R F M, Tai, L B, Leung, C C

“…Case report Accelerating diagnosis and treatment of rifampicin-resistant/multidrug-resistant tuberculosis (MDR-TB) are key components of the World Health…”
Get full text

Unusual high number of spike protein mutations for the SARS-CoV-2 strains detected in Hong Kong by Tsang, Alan KL, Cheng, Peter KC, Mak, Gannon CK, Leung, Patricia KL, Yip, Peter CW, Lam, Edman TK, Ng, Ken HL, Chan, Rickjason CW

Get full text

Prevalences of levofloxacin resistance and pncA mutation in isoniazid-resistant Mycobacterium tuberculosis in Hong Kong by Ng, K K M, Yip, P C W, Leung, P K L

“…In 2018, the World Health Organization recommended a 6-month treatment regimen that included levofloxacin and pyrazinamide for isoniazid-resistant without…”
Get full text

Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong by Chan, Raphael C. Y., Hui, Mamie, Chan, Edward W. C., Au, T. K., Chin, Miu L., Yip, Chun K., AuYeang, Carrie K. W., Yeung, Christina Y. L., Kam, Kai M., Yip, Peter C. W., Cheng, Augustine F. B.

“…Objectives To characterize 250 drug-resistant Mycobacterium tuberculosis (MTB) isolates in Hong Kong with respect to their drug susceptibility phenotypes to…”
Get full text

Prevalences of levofloxacin resistance and pncA by Ng, Kevin KM, Peter CW Yip, Leung, Patricia KL

“…Introduction: In 2018, the World Health Organization recommended a 6-month treatment regimen that included levofloxacin and pyrazinamide for…”
Get full text

Genotypic rpoB and gyrA profiles for detection of rifampicin and fluoroquinolone susceptibilities of Mycobacterium tuberculosis isolates directly from clinical sputum specimens by Hui, Mamie, Chan, Edward W.C, Chin, Miu L, Au, T.K, Yip, Peter C.W, Kam, Kai M, Yew, Wing W, Chan, Raphael C.Y

Get full text